Business Context and Reporting Period
Company: Amerigon Incorporated (Note: Input metadata referenced "Gentherm Inc," but the filing text identifies the registrant as Amerigon Incorporated).
Reporting Period: Fiscal year ended December 31, 2007.
Business Overview: Amerigon designs, develops, and markets proprietary thermoelectric device (TED) technologies. Its primary product is the Climate Control Seat (CCS), which provides active heating and cooling for automotive seats. The company operates as a Tier II supplier to major Original Equipment Manufacturers (OEMs) including Ford, General Motors, Toyota, Nissan, and Hyundai. In late 2007, the company began producing components for its first non-automotive product, the C2 Climate Control device, marketed by Herman Miller.
Key Financial Metrics
| Metric | 2007 | 2006 | 2005 |
|---|---|---|---|
| Product Revenues | $63,630,000 | $50,609,000 | $35,737,000 |
| Gross Margin | $21,328,000 (33.5%) | $16,500,000 (32.6%) | $10,665,000 (29.8%) |
| Operating Income | $7,705,000 | $5,513,000 | $2,570,000 |
| Net Income | $7,375,000 | $3,514,000 | $16,549,000 |
| Diluted EPS | $0.33 | $0.16 | $0.76 |
| Cash & Cash Equivalents | $1,170,000 | $2,440,000 | $1,364,000 |
| Short-term Investments | $23,925,000 | $12,076,000 | $12,076,000 |
| Working Capital | $30,538,000 | $23,765,000 | $15,646,000 |
| Long-term Obligations | $450,000 | $650,000 | $850,000 |
Liquidity: The company maintains a $10,000,000 revolving credit line with Comerica Bank. As of December 31, 2007, no loans were outstanding, and $9,835,000 was available.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 26% to $63.6 million, driven by new model introductions (e.g., Jaguar XJ, Hyundai Genesis) and higher volumes on redesigned models. Unit shipments rose to 939,000 from 718,000 in 2006.
- Profitability: Operating income increased 40% to $7.7 million. Net income more than doubled to $7.4 million, aided by a $1.7 million deferred tax benefit from recognized R&D credits.
- Expense Increases: Net R&D expenses rose 51% to $5.1 million due to increased activity in advanced TED programs and lower reimbursements following an amendment to the Visteon partnership agreement. SG&A expenses increased 12% to $8.5 million, reflecting higher marketing costs and management incentives.
- Balance Sheet: Short-term investments increased by $11.8 million, while inventory decreased by 49% due to management efforts to reduce stock levels and increased direct shipping from contract manufacturers.
Guidance, Outlook, and Risks
- Outlook: Management expects product revenues to grow 30% to 40% in 2008, driven by new program launches and the full-year effect of 2007 launches, partially offset by softness in the North American automotive market.
- Product Pipeline: A ventilated-only variant of the CCS (no active cooling) is scheduled for launch in 2008 to target lower-cost vehicle models. The C2 Climate Control device is expected to be available in January 2008.
- Risks:
- Customer Concentration: Three customers (NHK, Lear, Bridgewater) accounted for 85% of total revenues in 2007. Loss of any one would have a material adverse impact.
- Supply Chain: Production is outsourced to contract manufacturers in China, Mexico, and Japan, exposing the company to logistics risks and potential production interruptions.
- Technology: Future growth depends on the commercialization of advanced TED technologies, which require further efficiency improvements and material advancements that are not guaranteed.
- Patents: One of three licensed patents from Feher Design, Inc. expires in November 2008.
Key Facts for Investor Verification
- Customer Dependency: Verify the stability of relationships with NHK, Lear, and Bridgewater, which collectively represent 85% of revenue.
- 2008 Growth Targets: Monitor Q1 and Q2 2008 results to confirm the projected 30-40% revenue growth against the backdrop of a softening North American auto market.
- R&D Reimbursements: Track the status of new partnership agreements for the BSST subsidiary to determine if R&D reimbursements will recover to offset the increased net R&D expenses seen in 2007.
- Patent Expiration: Assess the impact of the Feher Design patent expiration in November 2008 on the CCS product line.
- Inventory Management: Confirm that the 49% reduction in inventory levels does not lead to supply chain bottlenecks as production volumes increase in 2008.